Your browser doesn't support javascript.
loading
Community tuberculosis screening, testing and care, Uganda.
Turyahabwe, Stavia; Bamuloba, Muzamiru; Mugenyi, Levicatus; Amanya, Geoffrey; Byaruhanga, Raymond; Imoko, Joseph Fry; Nakawooya, Mabel; Walusimbi, Simon; Nidoi, Jasper; Burua, Aldomoro; Sekadde, Moorine; Muttamba, Winters; Arinaitwe, Moses; Henry, Luzze; Kengonzi, Rose; Mudiope, Mary; Kirenga, Bruce J.
Affiliation
  • Turyahabwe S; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Bamuloba M; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Mugenyi L; Department of Statistics, The Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda.
  • Amanya G; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Byaruhanga R; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Imoko JF; Department of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
  • Nakawooya M; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Walusimbi S; Department of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
  • Nidoi J; Department of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
  • Burua A; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Sekadde M; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Muttamba W; Department of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
  • Arinaitwe M; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Henry L; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Kengonzi R; National TB and Leprosy Program, Ministry of Health, Uganda, 6 Lourdel Road, Wandegeya, Kampala, Uganda.
  • Mudiope M; Department of Health Systems Strengthening, Infectious Diseases Institute, Kampala, Uganda.
  • Kirenga BJ; Department of Research and Innovation, Makerere University Lung Institute, Kampala, Uganda.
Bull World Health Organ ; 102(6): 400-409, 2024 Jun 01.
Article in En | MEDLINE | ID: mdl-38812802
ABSTRACT

Objective:

To assess the effectiveness of a community-based tuberculosis and leprosy intervention in which village health teams and health workers conduct door-to-door tuberculosis screening, targeted screenings and contact tracing.

Methods:

We conducted a before-and-after implementation study in Uganda to assess the effectiveness of the community tuberculosis intervention by looking at reach, outputs, adoption and effectiveness of the intervention. Campaign 1 was conducted in March 2022 and campaign 2 in September 2022. We calculated percentages of targets achieved and compared case notification rates during the intervention with corresponding quarters in the previous year. We also assessed the leprosy screening.

Findings:

Over 5 days, campaign 1 screened 1 289 213 people (2.9% of the general population), of whom 179 144 (13.9%) fulfilled the presumptive tuberculosis criteria, and 4043 (2.3%) were diagnosed with bacteriologically-confirmed tuberculosis; 3710 (91.8%) individuals were linked to care. In campaign 2, 5 134 056 people (11.6% of the general population) were screened, detecting 428 444 (8.3%) presumptive tuberculosis patients and 8121 (1.9%) bacteriologically-confirmed tuberculosis patients; 5942 individuals (87.1%) were linked to care. The case notification rate increased from 48.1 to 59.5 per 100 000 population in campaign 1, with a case notification rate ratio of 1.24 (95% confidence interval, CI 1.22-1.26). In campaign 2, the case notification rate increased from 45.0 to 71.6 per 100 000 population, with a case notification rate ratio of 1.59 (95% CI 1.56-1.62). Of the 176 patients identified with leprosy, 137 (77.8%) initiated treatment.

Conclusion:

This community tuberculosis screening initiative is effective. However, continuous monitoring and adaptations are needed to overcome context-specific implementation challenges.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Mass Screening Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Bull World Health Organ Year: 2024 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / Mass Screening Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: Africa Language: En Journal: Bull World Health Organ Year: 2024 Document type: Article Affiliation country: Country of publication: